Immune cascades in human intervertebral disc: The pros and cons

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 6, 2013, Pages 1009-1014

  Sun, Zhen ^a   Zhang, Ming ^b   Zhao, Xu Hong ^c   Liu, Zhi Heng ^a   Gao, Yang ^a   Samartzis, Dino ^d   Wang, Hai Qiang ^a   Luo, Zhuo Jing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Immune privilege; Immune reaction; Intervertebral disc degeneration; Nucleus pulposus

Indexed keywords

ARTICLE; HUMAN; IMMUNE PRIVILEGE; IMMUNITY; IMMUNOLOGY; INTERVERTEBRAL DISK; INTERVERTEBRAL DISK DEGENERATION; INTERVERTEBRAL DISK HERNIA; NUCLEUS PULPOSUS; PATHOLOGY; PROGNOSIS; SIGNAL TRANSDUCTION;

IMMUNE PRIVILEGE; IMMUNE REACTION; INTERVERTEBRAL DISC DEGENERATION; NUCLEUS PULPOSUS;

HUMANS; INTERVERTEBRAL DISC; INTERVERTEBRAL DISC DEGENERATION; INTERVERTEBRAL DISC DISPLACEMENT; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84883010445     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Freemont AJ. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 2009; 48: 5-10.
2. Hughes SP, Freemont AJ, Hukins DW, Mc-Gregor AH and Roberts S. The pathogenesis of degeneration of the intervertebral disc and emerging therapies in the management of back pain. J Bone Joint Surg Br 2012; 94: 1298-1304.
3. Salzberg L. The physiology of low back pain. Prim Care 2012; 39: 487-498.
4. Herkowitz HN, Abraham DJ, and Albert TJ. Management of degenerative disc disease above an L5-S1 segment requiring arthrodesis. Spine (Phila Pa 1976) 1999; 24: 1268-1270.
5. Miyamoto M, Genbum Y, and Ito H. [Diagnosis, and treatment of lumbar spinal canal stenosis]. J Nippon Med Sch 2002; 69: 583-587.
6. Mirza SK, and White AA 3rd. Anatomy of intervertebral disc, and pathophysiology of herniated disc disease. J Clin Laser Med Surg 1995; 13: 131-142.
7. Gertzbein SD, Tait JH, and Devlin SR. The stimulation of lymphocytes by nucleus pulposus in patients with degenerative disk disease of the lumbar spine. Clin Orthop Relat Res 1977; 149-154.
8. McCarron RF, Wimpee MW, Hudkins PG, and Laros GS. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low-back pain. Spine (Phila Pa 1976) 1987; 12: 760-764.
9. Murai K, Sakai D, Nakamura Y, Nakai T, Igarashi T, Seo N, Murakami T, Kobayashi E, and Mochida J. Primary immune system responders to nucleus pulposus cells: evidence for immune response in disc herniation. Eur Cell Mater 2010; 19: 13-21.
10. Gabr MA, Jing L, Helbling AR, Sinclair SM, Allen KD, Shamji MF, Richardson WJ, Fitch RD, Setton LA, and Chen J. Interleukin-17 synergizes with IFNgamma or TNFalpha to promote inflammatory mediator release, and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J Orthop Res 2011; 29: 1-7.
11. Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue,, and to the anterior chamber of the eye. Br J Exp Pathol 1948; 29: 58-69.
12. Crane IJ, Xu H, Wallace C, Manivannan A, Mack M, Liversidge J, Marquez G, Sharp PF, and Forrester JV. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J Leukoc Biol 2006; 79: 435-443.
13. Muldoon LL, Alvarez JI, Begley DJ, Boado RJ, Del Zoppo GJ, Doolittle ND, Engelhardt B, Hallenbeck JM, Lonser RR, Ohlfest JR, Prat A, Scarpa M, Smeyne RJ, Drewes LR, and Neuwelt EA. Immunologic privilege in the central nervous system, and the blood-brain barrier. J Cereb Blood Flow Metab 2013; 33: 13-21.
14. Kaneyama S, Nishida K, Takada T, Suzuki T, Shimomura T, Maeno K, Kurosaka M, and Doita M. Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J Orthop Sci 2008; 13: 130-135.
15. Takada T, Nishida K, Doita M, and Kurosaka M. Fas ligand exists on intervertebral disc cells: a potential molecular mechanism for immune privilege of the disc. Spine (Phila Pa 1976) 2002; 27: 1526-1530.
16. Wang HQ, Yu XD, Liu ZH, Cheng X, Samartzis D, Jia LT, Wu SX, Huang J, Chen J, and Luo ZJ. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD, and caspase-3. J Pathol 2011; 225: 232-242.
17. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, and Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630-632.
18. Greil R, Egle A, and Villunger A. On the role, and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues, and cancer cells using multiple myeloma as a model. Leuk Lymphoma 1998; 31: 477-490.
19. Griffith TS, Brunner T, Fletcher SM, Green DR, and Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
20. Park JB, Chang H, and Kim KW. Expression of Fas ligand, and apoptosis of disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001; 26: 618-621.
21. Park JB, Kim KW, Han CW, and Chang H. Expression of Fas receptor on disc cells in herniated lumbar disc tissue. Spine (Phila Pa 1976) 2001; 26: 142-146.
22. Wang F, Jiang JM, Deng CH, Wang FL, Fu ZZ, and Zhang ZF. Expression of Fas receptor, and apoptosis in vertebral endplates with degenerative disc diseases categorized as Modic type I or II. Injury 2011; 42: 790-795.
23. Tschoeke SK, Hellmuth M, Hostmann A, Robinson Y, Ertel W, Oberholzer A, and Heyde CE. Apoptosis of human intervertebral discs after trauma compares to degenerated discs involving both receptor-mediated, and mitochondrialdependent pathways. J Orthop Res 2008; 26: 999-1006.
24. Tsuru M, Nagata K, Ueno T, Jimi A, Irie K, Yamada A, Nishida T, and Sata M. Electron microscopic observation of established chondrocytes derived from human intervertebral disc hernia (KTN-1), and role of macrophages in spontaneous regression of degenerated tissues. Spine J 2001; 1: 422-431.
25. Tapia-Perez H. [Intervertebral disc pathologies from an immunological perspective]. Rev Neurol 2008; 46: 751-757.
26. Wan J, and Zhang XS. Pre-operative blood test for antibody to nucleus pulposus may distinguish types of lumbar disc herniation. Med Hypotheses 2010; 75: 464-465.
27. Kauppila LI. Ingrowth of blood vessels in disc degeneration. Angiographic, and histological studies of cadaveric spines. J Bone Joint Surg Am 1995; 77: 26-31.
28. Roberts S, Evans H, Trivedi J, and Menage J. Histology, and Pathology of the Human Intervertebral Disc. J Bone Joint Surgery Am 2006; 88: 10-14.
29. Karppinen J, Korhonen T, Malmivaara A, Paimela L, Kyllonen E, Lindgren KA, Rantanen P, Tervonen O, Niinimaki J, Seitsalo S, and Hurri H. Tumor necrosis factor-alpha monoclonal antibody, infliximab, used to manage severe sciatica. Spine (Phila Pa 1976) 2003; 28: 750-753; discussion 753-754.
30. Gronert K. Resolution, the grail for healthy ocular inflammation. Exp Eye Res 2010; 91: 478-485.
31. Nishihira J. Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med 1998; 2: 17-28.
32. Arakawa T, Watanabe T, Tanigawa T, Tominaga K, Fujiwara Y, and Morimoto K. Quality of ulcer healing in gastrointestinal tract: its pathophysiology, and clinical relevance. World J Gastroenterol 2012; 18: 4811-4822.
33. Gethin G. Understanding the inflammatory process in wound healing. Br J Community Nurs 2012; Suppl: S17-18, S20, S22.
34. Weidenbusch M, and Anders HJ. Tissue microenvironments define, and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair, and fibrosis. J Innate Immun 2012; 4: 463-477.
35. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, Plonquet A, Gherardi RK, and Chazaud B. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057-1069.
36. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, and Pittet MJ. The healing myocardium sequentially mobilizes two monocyte subsets with divergent, and complementary functions. J Exp Med 2007; 204: 3037-3047.
37. Shechter R, London A, Varol C, Raposo C, Cusimano M, Yovel G, Rolls A, Mack M, Pluchino S, Martino G, Jung S, and Schwartz M. Infiltrating blood-derived macrophages are vital cells playing an anti-inflammatory role in recovery from spinal cord injury in mice. PLoS Med 2009; 6: e1000113.
38. London A, Itskovich E, Benhar I, Kalchenko V, Mack M, Jung S, and Schwartz M. Neuroprotection, and progenitor cell renewal in the injured adult murine retina requires healing monocytederived macrophages. J Exp Med 2011; 208: 23-39.
39. Modic MT. Degenerative disc disease, and back pain. Magn Reson Imaging Clin N Am 1999; 7: 481-491, viii.
40. Singh K, Masuda K, and An HS. Animal models for human disc degeneration. Spine J 2005; 5: 267S-279S.
41. Peng B, Hao J, Hou S, Wu W, Jiang D, Fu X, and Yang Y. Possible pathogenesis of painful intervertebral disc degeneration. Spine (Phila Pa 1976) 2006; 31: 560-566.
42. Geiss A, Larsson K, Rydevik B, Takahashi I, and Olmarker K. Autoimmune properties of nucleus pulposus: an experimental study in pigs. Spine (Phila Pa 1976) 2007; 32: 168-173.
43. Weiler C, Nerlich AG, Schaaf R, Bachmeier BE, Wuertz K, and Boos N. Immunohistochemical identification of notochordal markers in cells in the aging human lumbar intervertebral disc. Eur Spine J 2010; 19: 1761-1770.
44. Ohtori S, Inoue G, Eguchi Y, Orita S, Takaso M, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Arai G, Miyagi M, Kamoda H, Suzuki M, Sakuma Y, Oikawa Y, Kubota G, Inage K, Sainoh T, Toyone T, Yamauchi K, Kotani T, Akazawa T, Minami S, and Takahashi K. Tumor Necrosis Factor-alpha-Immunoreactive Cells in Nucleus Pulposus in Adolescent Patients With Lumbar Disc Herniation. Spine (Phila Pa 1976) 2013; 38: 459-462.
45. Yamamoto J, Maeno K, Takada T, Kakutani K, Yurube T, Zhang Z, Hirata H, Kurakawa T, Sakai D, Mochida J, Doita M, Kurosaka M, and Nishida K. Fas ligand plays an important role for the production of pro-inflammatory cytokines in intervertebral disc nucleus pulposus cells. J Orthop Res 2013; 31: 608-615.
46. Andrade P, Hoogland G, Garcia MA, Steinbusch HW, Daemen MA, and Visser-Vandewalle V. Elevated IL-1beta, and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J 2013; 22: 714-20.
47. Doita M, Kanatani T, Ozaki T, Matsui N, Kurosaka M, and Yoshiya S. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine (Phila Pa 1976) 2001; 26: 1522-1527.
48. Ikeda T, Nakamura T, Kikuchi T, Umeda S, Senda H, and Takagi K. Pathomechanism of spontaneous regression of the herniated lumbar disc: histologic, and immunohistochemical study. J Spinal Disord 1996; 9: 136-140.